Advanced search
Publication Cover
Scandinavian Journal of Primary Health Care Volume 39, 2021 - Issue 4
Submit an article Journal homepage
1,230
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

Nicolay Jonassen Harbina Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, NorwayCorrespondence[email protected]
View further author information
,
Karin Rystedtb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, Sweden;e Region Västra Götaland, Närhälsan Stenstorp vårdcentral, Stenstorp, SwedenView further author information
,
Morten Lindbaeka Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, NorwayView further author information
,
Ruta Radzevicienef Mano Seimos gydytojas, Klaipeda, LithuaniaView further author information
,
Johan Westing Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenView further author information
,
Ronny Gunnarssonb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, SwedenView further author information
,
Christopher C. Butlerh Department of Primary Care Health Services, University of Oxford, Radcliffe Observatory Quarter, Oxford, UKView further author information
,
Alike W. van der Veldeni Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the NetherlandsView further author information
,
Theo J. Verheiji Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the NetherlandsView further author information
&
Pär-Daniel Sundvallb Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sweden;c General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg, Gothenburg, SwedenView further author information
 show all
Pages 527-532 | Received 26 Mar 2021, Accepted 11 Aug 2021, Published online: 01 Dec 2021

References

  • Cassini A, Colzani E, Pini A, et al. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European union and European economic area countries, 2009 to 2013. Euro Surveill. 2018;23(16):15–34.
  • Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362(9397):1733–1745.
  • WHO. Influenza (seasonal). 6. November 2018. (accessed on 20. October 2020) Available from: https://www-who-int.ezproxy.uio.no/news-room/fact-sheets/detail/influenza-(seasonal).
  • Fitzner J, Qasmieh S, Mounts AW, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96(2):122–128.
  • Simonsen KA, Hunskaar S, Wensaas KA, et al. Influenza-like illness in Norway: clinical course, attitudes towards vaccination and preventive measures during the 2009 pandemic. Fam Pract. 2012;29(2):139–146.
  • Butler CC, van der Velden AW, Bongard E, et al. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet. 2020;395(10217):42–52.
  • Adriaenssens N, ESAC Project Group, Coenen S, Kroes ACM, Versporten A, Vankerckhoven V, Muller A, et al. European surveillance of antimicrobial consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother. 2011;66(8):1897–1905.
  • Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;2014(4):Cd008965.
  • Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a Meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729–1737.
  • Neumark T, Brudin L, Mölstad S. Use of rapid diagnostic tests and choice of antibiotics in respiratory tract infections in primary healthcare–a 6-y follow-up study. Scand J Infect Dis. 2010;42(2):90–96.
  • Rebnord IK, Sandvik H, Hunskaar S. Use of laboratory tests in out-of-hours services in Norway. Scand J Prim Health Care. 2012;30(2):76–80.
  • Saust LT, Bjerrum L, Siersma V, et al. Quality assessment in general practice: diagnosis and antibiotic treatment of acute respiratory tract infections. Scand J Prim Health Care. 2018;36(4):372–379.
  • Moberg AB, Cronberg O, Falk M, et al. Change in the use of diagnostic tests in the management of lower respiratory tract infections: a register-based study in primary care. BJGP Open. 2020;4(1):bjgpopen20X101015.
  • Jakobsen KA, Melbye H, Kelly MJ, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28(4):229–236.
  • Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812.
  • Bray C, Bell LN, Liang H, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317–321.
  • Melbye H, Hvidsten D, Holm A, et al. The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract. 2004;54(506):653–658.
  • Rystedt K, Harbin NJ, Lindbaek M, et al. Is C-reactive protein associated with influenza a or B in primary care patients with influenza-like illness? A cross-sectional study. Scand J Prim Health Care. 2020;38(4):1–7.
  • Zimmerman O, Rogowski O, Aviram G, et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza a virus infection. BMC Infect Dis. 2010;10(1):288.
  • Tekin S, Keske S, Alan S, et al. Predictors of fatality in influenza a virus subtype infections among inpatients in the 2015-2016 season. Int J Infect Dis. 2019;81:6–9.
  • Haran JP, Suner S, Gardiner F. Correlation of C-reactive protein to severity of symptoms in acute influenza a infection. J Emerg Trauma Shock. 2012;5(2):149–152.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.